How to buy Thermogenesis stock (THMO)

Thermogenesis is a medical devices business based in the US. Thermogenesis shares (THMO) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.00 – an increase of 20% over the previous week. Thermogenesis employs 25 staff and has a trailing 12-month revenue of around $9.6 million.

Our top picks for where to buy Thermogenesis stock

Buy Thermogenesis stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Thermogenesis stock price (NASDAQ: THMO)

Use our graph to track the performance of THMO stocks over time.

Thermogenesis shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$0.00
52-week range	$0.00 - $1.25
50-day moving average more info button	$0.02
200-day moving average more info button	$0.31
Wall St. target price	$5.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-3.98

Is it a good time to buy Thermogenesis stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Thermogenesis price performance over time

Historical closes compared with the close of $0.0006 from 2024-12-20

1 week (2024-12-13)	20.00%
1 month (2024-11-22)	-14.29%
3 months (2024-09-20)	-99.66%
6 months (2024-06-21)	-99.74%

1 year (2023-12-22)	-99.90%
2 years (2022-12-22)	-99.99%
3 years (2021-12-22)	51.3
5 years (2019-12-20)	124.2

Thermogenesis financials

Revenue TTM	$9.6 million
Gross profit TTM	$3.5 million
Return on assets TTM	-25.5%
Return on equity TTM	-801.94%
Profit margin	-153.43%
Book value	$0.12
Market Capitalization more info button	$11,093

TTM: trailing 12 months

Thermogenesis share dividends

We're not expecting Thermogenesis to pay a dividend over the next 12 months.

Have Thermogenesis's shares ever split?

Thermogenesis's shares were split on a 1:45 basis on 21 December 2022 . So if you had owned 45 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Thermogenesis shares – just the quantity. However, indirectly, the new 4400% higher share price could have impacted the market appetite for Thermogenesis shares which in turn could have impacted Thermogenesis's share price.

Thermogenesis share price volatility

Over the last 12 months, Thermogenesis's shares have ranged in value from as little as $0.0005 up to $1.25. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Thermogenesis's is 2.445. This would suggest that Thermogenesis's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Thermogenesis overview

ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics in the United States, China, the United Arab Emirates, Vietnam, and internationally. The company provides medical device products for automated cell processing. Its clinical bio-banking applications include AXP II Automated Cell Separation System, an automated fully closed cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. The company's point-of-care applications include XP Point-of-Care System, an automated, fully closed, sterile system that allows for the rapid and automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; and PXP-1000 System, an automated, fully closed system that provides fast, reproducible separation of multiple cellular components from blood with minimal red blood cell contamination. Its cell processing products comprise X-Series products for general laboratory use, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The company also provides contract development and manufacturing services for cell and cell-based gene therapies.

Frequently asked questions

What percentage of Thermogenesis is owned by insiders?
Currently 28.019% of Thermogenesis shares are held by insiders. How many people work for Thermogenesis?
Latest data suggests 25 work at Thermogenesis. When does the fiscal year end for Thermogenesis?
Thermogenesis's fiscal year ends in December. Where is Thermogenesis based?
Thermogenesis's address is: 2711 Citrus Road, Rancho Cordova, CA, United States, 95742 What is Thermogenesis's ISIN number?
Thermogenesis's international securities identification number is: US88362L1008 What is Thermogenesis's CUSIP number?
Thermogenesis's Committee on Uniform Securities Identification Procedures number is: 883623209